SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$8.17
-0.08 (-0.97%)
Open$8.22
Previous Close$8.25
Day High$8.49
Day Low$8.09
52W High$18.90
52W Low$6.66
Volume—
Avg Volume1.07M
Market Cap933.13M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+706.7% upside
Current
$8.17
$8.17
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.58M | 357.40M | 350.63M |
| Net Income | 8.12M | 35.24M | 44.72M |
| Profit Margin | 9.0% | 9.9% | 12.8% |
| EBITDA | 8.52M | 65.64M | 71.27M |
| Free Cash Flow | — | 46.75M | 30.69M |
| Rev Growth | — | +16.3% | -1.3% |
| Debt/Equity | — | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |